Meditor Group Ltd - Q3 2013 holdings

$709 Million is the total value of Meditor Group Ltd's 36 reported holdings in Q3 2013. The portfolio turnover from Q2 2013 to Q3 2013 was 45.0% .

 Value Shares↓ Weighting
MRK SellMERCK & CO. INC.$83,154,000
-4.1%
1,746,600
-6.4%
11.73%
-0.1%
EXEL  EXELIXIS INC$69,840,000
+28.2%
12,000,0000.0%9.85%
+33.5%
ONXX SellONYX PHARMACEUTICALS INC$54,245,000
-35.1%
435,000
-54.8%
7.65%
-32.4%
ALKS SellALKERMES PLC$52,783,000
+8.3%
1,570,000
-7.6%
7.44%
+12.7%
JCPNQ NewJ.C. PENNEY CO INC$39,623,0004,500,000
+100.0%
5.59%
VVUS  VIVUS INC$39,128,000
-26.1%
4,207,2960.0%5.52%
-23.0%
BKS BuyBARNES & NOBLE INC$36,879,000
+164.1%
2,850,000
+225.7%
5.20%
+175.0%
NYX  NYSE EURONEXT$32,579,000
+1.4%
776,0700.0%4.59%
+5.6%
LIFE BuyLIFE TECHNOLOGIES CORP$31,952,000
+99.0%
427,000
+96.8%
4.51%
+107.2%
HPQ SellHEWLETT-PACKARD CO$24,273,000
-41.6%
1,156,423
-31.0%
3.42%
-39.2%
GOOGL SellGOOGLE INC-CL Acl a$20,542,000
-73.3%
23,452
-73.1%
2.90%
-72.2%
6107SC BuyURS CORP$20,281,000
+19.3%
377,324
+4.8%
2.86%
+24.2%
DDS NewDILLARDS INC-CL Acl a$19,184,000245,000
+100.0%
2.70%
ISIS SellISIS PHARMACEUTICALS INC$18,395,000
+31.7%
490,000
-5.8%
2.59%
+37.1%
SPY NewSPDR S&P 500 ETF TRUSTetf$18,096,000107,708
+100.0%
2.55%
ITMN SellINTERMUNE INC$15,765,000
+19.2%
1,025,000
-25.5%
2.22%
+24.1%
UHS BuyUNIVERSAL HEALTH SERVICES-Bcl b$15,748,000
+135.2%
210,000
+110.0%
2.22%
+144.9%
NKTR  NEKTAR THERAPEUTICS$15,145,000
-9.6%
1,450,0000.0%2.14%
-5.8%
AAPL SellAPPLE INC$14,303,000
-12.0%
30,000
-26.8%
2.02%
-8.4%
WCRX  WARNER CHILCOTT PLC-CLASS A$12,978,000
+15.2%
566,0000.0%1.83%
+19.9%
OREX BuyOREXIGEN THERAPEUTICS INC$12,873,000
+15.9%
2,100,000
+10.5%
1.82%
+20.7%
LBTYK  LIBERTY GLOBAL PLC-SERIES Ccl c$12,767,000
+11.1%
169,2540.0%1.80%
+15.7%
NBIX BuyNEUROCRINE BIOSCIENCES INC$11,886,000
+229.0%
1,050,000
+288.9%
1.68%
+242.7%
SHPG  SHIRE PLC-ADRadr$8,392,000
+26.0%
70,0000.0%1.18%
+31.2%
PACD BuyPACIFIC DRILLING SA$4,045,000
+50.4%
365,100
+32.8%
0.57%
+56.6%
BMRN NewBIOMARIN PHARMACEUTICAL INC$3,977,00055,100
+100.0%
0.56%
APC  ANADARKO PETROLEUM CORP$3,906,000
+8.2%
42,0000.0%0.55%
+12.7%
VALE  VALE SA-SP ADRadr$3,425,000
+18.7%
219,4000.0%0.48%
+23.5%
BAC  BANK OF AMERICA CORP$3,367,000
+7.3%
244,0000.0%0.48%
+11.8%
DAL  DELTA AIR LINES INC$2,925,000
+26.1%
124,0000.0%0.41%
+31.2%
MU SellMICRON TECHNOLOGY INC$2,708,000
-18.6%
155,000
-33.2%
0.38%
-15.1%
HAL SellHALLIBURTON CO$1,493,000
-34.9%
31,000
-43.6%
0.21%
-32.2%
CCL  CARNIVAL CORPctf$1,488,000
-4.9%
45,6000.0%0.21%
-0.9%
GTE NewGRAN TIERRA ENERGY INC$461,00063,000
+100.0%
0.06%
INFN NewINFINERA CORP$276,00024,400
+100.0%
0.04%
HTZ NewHERTZ GLOBAL HOLDINGS INC$266,00012,000
+100.0%
0.04%
MSFT ExitMICROSOFT CORP$0-20,000
-100.0%
-0.09%
SQNM ExitSEQUENOM INC$0-700,000
-100.0%
-0.40%
RIGL ExitRIGEL PHARMACEUTICALS INC$0-900,000
-100.0%
-0.41%
INFI ExitINFINITY PHARMACEUTICALS INC$0-250,000
-100.0%
-0.55%
NDAQ ExitNASDAQ OMX GROUP/THE$0-124,793
-100.0%
-0.55%
ECYT ExitENDOCYTE INC$0-335,000
-100.0%
-0.60%
ALNY ExitALNYLAM PHARMACEUTICALS INC$0-144,647
-100.0%
-0.61%
BMC ExitBMC SOFTWARE INC$0-147,000
-100.0%
-0.90%
OPTR ExitOPTIMER PHARMACEUTICALS INC$0-475,000
-100.0%
-0.93%
SFD ExitSMITHFIELD FOODS INC$0-651,000
-100.0%
-2.89%
BBRY ExitRESEARCH IN MOTION$0-2,210,000
-100.0%
-3.13%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2013-10-25
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
EXELIXIS INC43Q4 202388.9%
ALKERMES PLC31Q4 202062.6%
ISHARES MSCI INDIA ETF31Q4 20235.5%
WISDOMTREE INDIA EARNINGS FUND31Q4 20235.5%
ESPERION THERAPEUTICS INC27Q4 202334.4%
VIVUS INC15Q4 201621.3%
CELLDEX THERAPEUTICS14Q2 20202.7%
PROSHARES ULTRAPRO SHORT S&P5004Q4 20173.8%
PROSHARES ULTRASHORT S&P5004Q4 20173.0%
PROSHARES ULTRASHORT S&P 500 ETF3Q3 20190.8%

View Meditor Group Ltd's complete holdings history.

Latest significant ownerships (13-D/G)
Meditor Group Ltd Q3 2013 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
EXELIXIS, INC.April 09, 201915,001,0735.0%
VIVUS INCDecember 19, 20125,002,8965.0%
VIVUS INCMarch 21, 20126,177,5006.3%
VION PHARMACEUTICALS INCFebruary 15, 20085,736,2007.6%
CYPRESS BIOSCIENCE INCSeptember 26, 20071,864,6455.0%
ONYX PHARMACEUTICALS INCSeptember 12, 20072,627,8004.8%
ACUSPHERE INCJuly 26, 20071,839,4214.0%
NOVACEA INCJune 11, 2007800,0003.4%
ATHEROGENICS INCMay 02, 20071,361,8003.5%

View Meditor Group Ltd's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-04-11
13F-HR2024-01-04
SC 13G/A2024-01-03
13F-HR2023-10-31
13F-HR2023-07-25
13F-HR2023-04-10
13F-HR2023-01-05
SC 13G/A2023-01-04
13F-HR2022-11-07
13F-HR2022-07-18

View Meditor Group Ltd's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (709146000.0 != 709148000.0)

Export Meditor Group Ltd's holdings